| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | SIENTRA INC | 309,300 | 1,831,000 | 0.77% | ||
| 52 | FLEX PHARMA INC COM | 142,000 | 1,768,000 | 0.75% | ||
| 53 | TONIX PHARMACEUTICALS HOLDING | 217,900 | 1,671,000 | 0.71% | ||
| 54 | HALYARD HEALTH INC | 44,573 | 1,489,000 | 0.63% | ||
| 55 | Intersect ENT Inc | 55,000 | 1,238,000 | 0.52% | ||
| 56 | ALLIQUA BIOMEDICAL INC | 523,000 | 1,119,000 | 0.47% | ||
| 57 | ATRICURE INC | 48,450 | 1,087,000 | 0.46% | ||
| 58 | AKORN INCORPORATED | 28,500 | 1,063,000 | 0.45% | ||
| 59 | ALIGN TECHNOLOGY INC | 55,000 | 986,000 | 0.42% | Put | |
| 60 | TANDEM DIABETES CARE INC COM | 82,873 | 979,000 | 0.41% | ||
| 61 | ZOGENIX INC | 58,750 | 866,000 | 0.37% | ||
| 62 | FOAMIX PHARMACEUTICALS LTD | 102,000 | 827,000 | 0.35% | ||
| 63 | ACCURAY INCORPORATED COM | 100,000 | 675,000 | 0.28% | Call | |
| 64 | WRIGHT MED GROUP N V | 585,436 | 596,000 | 0.25% | ||
| 65 | FIVE PRIME THERAPEUTICS INC | 13,500 | 560,000 | 0.24% | ||
| 66 | ADAMIS PHARMACEUTICALS CORP | 80,500 | 435,000 | 0.18% | ||
| 67 | OCERA THERAPEUTICS INC | 131,000 | 409,000 | 0.17% | ||
| 68 | Aldeyra Therapeutics Inc | 57,500 | 390,000 | 0.16% | ||
| 69 | CYMABAY THERAPEUTICS INC | 200,000 | 338,000 | 0.14% | ||
| 70 | ENDOCHOICE HLDGS INC | 40,000 | 334,000 | 0.14% | ||
| 71 | ALIMERA SCIENCES INC | 129,597 | 314,000 | 0.13% | ||
| 72 | INOTEK PHARMACEUTICALS CORP | 26,800 | 304,000 | 0.13% | ||
| 73 | SPECTRANETICS CORP | 20,000 | 301,000 | 0.13% | Call | |
| 74 | Carbylan Therapeutics Inc. | 80,000 | 290,000 | 0.12% | ||
| 75 | SAREPTA THERAPEUTICS INC | 5,400 | 208,000 | 0.09% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-16-007394, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
